Home

CINP 2018

Read time: 4 min

Biasing the system: investigating factors in risk and resilience for psychiatric disease

The aim of this lecture by Professor Elizabeth Binder of the Max Planck Institute of Psychiatry,...

Read time: 5 min

Managing the burdens of bipolar disorder

The cognitive and physiological burdens of bipolar disorder, and some approaches to its treatment,...

Bipolar, Schizophrenia

Read time: 4 min

Controversial issues in the management of schizophrenia

Controversial issues in the management of schizophrenia — brain shrinkage, dopamine...

Read time: 3 min

Brain circuits in depression and response to pharmacotherapy

The symptoms of major depressive disorder (MDD) vary from patient to patient. The primary treatment...

Read time: 3 min

Survey reveals intriguing differences between Asian countries in antipsychotic prescribing, symptoms, and adverse event reporting

The Research on Asian Psychotropic Prescription Pattern (REAP) studies provide unique insights into...

Read time: 5 min

Improving cognition and motivation in schizophrenia to address patient’s goal of restoring social functioning

In schizophrenia, a patient’s goal of ‘personal recovery’ may be different from...

Read time: 3 min

Optimizing therapy in schizophrenia — addressing cognition, function, and cardiovascular disease risk factors

Patients with schizophrenia not only experience symptoms that adversely affect their ability to...

Alzheimer's Disease

Read time: 4 min

Unpicking Alzheimer disease and depression

In this symposium four speakers discussed different approaches to investigating the intersection...

Read time: 3 min

Steps towards more effective and better tolerated treatment options for schizophrenia

New more effective and better tolerated treatments for schizophrenia are needed to improve patient...

Read time: 4 min

Role of the CINP 2017 Treatment Guidelines for Bipolar Disorder in clinical practice

The CINP 2017 Treatment Guidelines for Bipolar Disorder have been developed from a detailed...

Read time: 5 min

Impaired working memory — from gene to cell to circuit to system to behavior

Mouse models carrying a schizophrenia-predisposing mutation equivalent to the 22q11.2 microdeletion...

Read time: 6 min

New understanding of the gut microbiome may be the key to many diseases and pave the way for new therapies

The role of the gut microbiome in a range of psychiatric disorders, including depression and...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country